Clarius Group LLC’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $723K | Sell |
1,625
-193
| -11% | -$85.9K | 0.04% | 188 |
|
2025
Q1 | $881K | Buy |
1,818
+440
| +32% | +$213K | 0.06% | 158 |
|
2024
Q4 | $555K | Sell |
1,378
-130
| -9% | -$52.4K | 0.04% | 203 |
|
2024
Q3 | $700K | Sell |
1,508
-48
| -3% | -$22.3K | 0.05% | 162 |
|
2024
Q2 | $729K | Sell |
1,556
-94
| -6% | -$44.1K | 0.05% | 158 |
|
2024
Q1 | $690K | Sell |
1,650
-308
| -16% | -$129K | 0.05% | 173 |
|
2023
Q4 | $797K | Sell |
1,958
-127
| -6% | -$51.7K | 0.07% | 157 |
|
2023
Q3 | $725K | Sell |
2,085
-415
| -17% | -$144K | 0.07% | 156 |
|
2023
Q2 | $880K | Buy |
2,500
+48
| +2% | +$16.9K | 0.07% | 153 |
|
2023
Q1 | $773K | Sell |
2,452
-110
| -4% | -$34.7K | 0.07% | 169 |
|
2022
Q4 | $740K | Buy |
2,562
+62
| +2% | +$17.9K | 0.07% | 175 |
|
2022
Q3 | $724K | Buy |
2,500
+64
| +3% | +$18.5K | 0.07% | 161 |
|
2022
Q2 | $686K | Buy |
2,436
+316
| +15% | +$89K | 0.07% | 174 |
|
2022
Q1 | $466K | Hold |
2,120
| – | – | 0.04% | 254 |
|
2021
Q4 | $466K | Sell |
2,120
-76
| -3% | -$16.7K | 0.04% | 254 |
|
2021
Q3 | $398K | Buy |
2,196
+85
| +4% | +$15.4K | 0.04% | 260 |
|
2021
Q2 | $426K | Sell |
2,111
-23
| -1% | -$4.64K | 0.04% | 243 |
|
2021
Q1 | $459K | Buy |
2,134
+320
| +18% | +$68.8K | 0.05% | 207 |
|
2020
Q4 | $429K | Buy |
1,814
+132
| +8% | +$31.2K | 0.05% | 194 |
|
2020
Q3 | $458K | Sell |
1,682
-27
| -2% | -$7.35K | 0.06% | 149 |
|
2020
Q2 | $496K | Buy |
1,709
+155
| +10% | +$45K | 0.07% | 136 |
|
2020
Q1 | $370K | Buy |
1,554
+103
| +7% | +$24.5K | 0.07% | 148 |
|
2019
Q4 | $340K | Buy |
1,451
+43
| +3% | +$10.1K | 0.05% | 185 |
|
2019
Q3 | $239K | Buy |
+1,408
| New | +$239K | 0.04% | 238 |
|
2019
Q2 | – | Sell |
-1,152
| Closed | -$212K | – | 270 |
|
2019
Q1 | $212K | Buy |
+1,152
| New | +$212K | 0.05% | 196 |
|